Assessment of Response to B-Cell Depletion Using Rituximab in Cutaneous Lupus Erythematosus

This cohort study evaluates outcomes of rituximab treatment in patients with different clinical subtypes of cutaneous lupus erythematosus and associated systemic disease.

https://ift.tt/2RsT51y